Link Pharma Chem Share Price

Link Pharma Chem Share Price

  • 26.450.01 (0.03%)
BSE
  • Live
  • As On: 19 Jun, 2026, 03:40 PM IST
Loading...
Open-
High-
Low-
Prev Close-
Volume-
VWAP(₹)-

Key Metrics

PE Ratio(x)152.34
EPS - TTM(₹)0.17
MCap(₹ Cr.)11.75
MCap Rank168
PB Ratio(x)0.92
Div Yield(%)-
Face Value(₹)10.00
52W High(₹)42.80
52W Low(₹)21.00
MCap/Sales0.37
Beta(1 Month)-0.59
BV/Share(₹)28.80

Link Pharma share price insights

  • Employee & Interest Expense

    Company has spent 1.93% of its operating revenues towards interest expenses and 22.19% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • Link Pharma Share Price Update

    Link Pharma Chem Ltd. share price moved up by 0.03% from its previous close of Rs 26.44. Link Pharma Chem Ltd. stock last traded price is 26.45

    Share PriceValue
    Today/Current/Last26.45
    Previous Day26.44

Found Insights useful?

Link Pharma Share Price Returns

1 Day0.03%
1 Month-9.2%
3 Months6.4%
1 Year-30.16%
3 Years-36.4%
5 Years-23.44%

Link Pharma Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income6.746.536.348.026.56
    Total Income Growth (%)3.103.04-20.9722.2337.31
    Total Expenses7.076.296.207.416.91
    Total Expenses Growth (%)12.521.39-16.337.3126.33
    EBIT-0.340.250.140.61-0.34
    EBIT Growth (%)-236.2675.59-77.04--
    Profit after Tax (PAT)-0.410.070.020.40-0.35
    PAT Growth (%)-699.12337.18-96.12--
    EBIT Margin (%)-5.003.792.227.65-5.20
    Net Profit Margin (%)-6.071.040.255.01-5.33
    Basic EPS (₹)-0.920.150.030.91-0.79
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue27.6325.6230.5438.6154.03
    Total Revenue Growth (%)7.86-16.10-20.91-28.5355.09
    Total Expenses27.5027.0232.4537.7251.40
    Total Expenses Growth (%)1.77-16.74-13.97-26.6155.04
    Profit after Tax (PAT)0.08-1.03-1.360.651.88
    PAT Growth (%)---308.33-65.2373.46
    Operating Profit Margin (%)2.42-2.46-3.494.255.73
    Net Profit Margin (%)0.28-4.03-4.551.683.51
    Basic EPS (₹)0.17-2.31-3.071.474.24

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Employee & Interest Expense

      Company has spent 1.93% of its operating revenues towards interest expenses and 22.19% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets24.9623.2925.9532.4628.96
    Total Assets Growth (%)7.17-10.25-20.0612.0910.53
    Total Liabilities12.1710.6312.2417.4214.49
    Total Liabilities Growth (%)14.49-13.15-29.7420.226.23
    Total Equity12.7912.6613.7115.0414.47
    Total Equity Growth (%)1.03-7.66-8.843.9415.21
    Current Ratio (x)1.011.111.051.211.28
    Total Debt to Equity (x)0.570.460.670.580.44
    Contingent Liabilities0.000.160.400.230.31

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities2.152.69-0.03-1.71-1.25
    Net Cash used in Investing Activities-2.661.530.41-0.08-4.98
    Net Cash flow from Financing Activities0.99-4.21-0.411.612.27
    Net Cash Flow0.483,000.00-0.03-0.17-3.95
    Closing Cash & Cash Equivalent0.550.060.060.090.27
    Closing Cash & Cash Equivalent Growth (%)746.200.47-31.63-64.94-93.66
    Total Debt/ CFO (x)3.402.15-329.35-5.13-5.11

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)0.60-8.11-9.944.3412.99
    Return on Capital Employed (%)4.84-4.73-6.989.1816.74
    Return on Assets (%)0.30-4.41-5.252.016.49
    Interest Coverage Ratio (x)3.100.41-0.013.388.87
    Asset Turnover Ratio (x)1.141.031.021.261.94
    Price to Earnings (x)131.58-14.62-13.7224.889.51
    Price to Book (x)0.791.191.361.081.23
    EV/EBITDA (x)10.1765.63-2,928.749.665.84
    EBITDA Margin (%)5.991.24-0.036.637.46

    No Data Available

Found Financials useful?

Technicals

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters23,26,93652.40 %0.90
    Pledge00.00 %0.00
    DII7000.02 %0.00
    MF7000.02 %0.00
    Others21,12,93247.58 %-0.90
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters52.4051.4951.4951.49
    Pledge0.000.000.000.00
    FII0.000.000.000.00
    DII0.020.020.020.02
    Mutual Funds0.020.020.020.02
    Others47.5848.4848.4848.48

Mutual Funds Ownership

No Data Available

Corporate Actions

  • Board Meeting

    Audited Results

    May 14, 2026

    Board Meeting

    Quarterly Results

    Feb 09, 2026

    Board Meeting

    Quarterly Results

    Nov 06, 2025

  • Announced onMeeting on
    May 14, 2026May 21, 2026
    Audited Results
    Feb 09, 2026Feb 14, 2026
    Quarterly Results
    Nov 06, 2025Nov 13, 2025
    Quarterly Results
    Jul 24, 2025Aug 01, 2025
    Quarterly Results
    May 19, 2025May 27, 2025
    Audited Results
  • No Data Available

  • No Data Available

  • No Data Available

  • No Data Available

  • Announced onMeeting on
    Aug 13, 2025Sep 09, 2025
    -
    Sep 16, 2024Sep 27, 2024
    A.G.M.
    Aug 29, 2023Sep 21, 2023
    A.G.M.
    Aug 02, 2021Aug 27, 2021
    Book closure from Aug 21, 2021 to Aug 27, 2021
    Aug 26, 2020Sep 24, 2020
    Book closure from Sep 18, 2020 to Sep 24, 2020

About Link Pharma

Link Pharma Chem Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 11.75 Crore) operating in Chemicals sector.

Show More

Key Indices Listed On

-

Address

162, GIDC Estate,Nandesari,Vadodra District, Gujarat - 391340

Executive Leadership

ST

Satish Thakur

Chairman & Wholetime Director
RT

Rishikesh Thakur

Managing Director
RG

Rachna Ghai

Independent Director
RS

Rangoli S Gada

Independent Director
Show More

Auditors

CNK & Associates LLP
Sanjay Soni & Associates

FAQs about Link Pharma share

  • 1. What is Link Pharma share price and what are the returns for Link Pharma share?
    As on 19 Jun, 2026, 03:40 PM IST Link Pharma share price is up by 0.03% basis the previous closing price of Rs 26.44. Link Pharma share price is Rs 26.45. Return Performance of Link Pharma Shares:
    • 1 Week: Link Pharma share price moved down by 2.94%
  • 2. What is Link Pharma's 52 week high / low?
    Link Pharma share price saw a 52 week high of Rs 42.80 and 52 week low of Rs 21.00.
  • 3. What's the market capitalization of Link Pharma?
    Market Capitalization of Link Pharma stock is Rs 11.75 Cr.
  • 4. What is the PE & PB ratio of Link Pharma?
    The PE ratio of Link Pharma stands at 152.34, while the PB ratio is 0.92.
  • 5. What are the returns for Link Pharma share?
    Return Performance of Link Pharma Shares:
    • 1 Week: Link Pharma share price moved down by 2.94%

Top Gainers

As on 11:10 AM | 22 Jun 2026
Kirloskar Oil
2,389.80
398.31 (20.01%)
Kirloskar Bros.
2,137.70
204.10 (10.56%)
Clean Science & Tech
835.15
53.00 (6.78%)
Aegis Logistics
1,070.40
62.61 (6.22%)
Tata Comm
2,104.20
115.40 (5.81%)

Top Losers

As on 11:10 AM | 22 Jun 2026
Craftsman Automation
9,352.00
-454.50 (-4.64%)
Reliance Infra
77.78
-3.77 (-4.63%)
Carborundum Uni
1,200.20
-41.50 (-3.35%)
Aadhar Housing Fin
500.50
-14.61 (-2.84%)
Gujarat Gas
377.70
-10.75 (-2.77%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.